Literature DB >> 7492040

Clinical safety of lidocaine in patients with cocaine-associated myocardial infarction.

R D Shih1, J E Hollander, J L Burstein, L S Nelson, R S Hoffman, A M Quick.   

Abstract

STUDY
OBJECTIVE: To evaluate the safety of lidocaine in the setting of cocaine-induced myocardial infarction (MI).
DESIGN: A retrospective, multicenter study.
SETTING: Twenty-nine university, university-affiliated, or community hospitals during a 6-year period (total of 117 cumulative hospital-years). PARTICIPANTS: Patients with cocaine-associated MI who received lidocaine in the emergency department.
RESULTS: Of 29 patients who received lidocaine in the setting of cocaine-associated MI, no patient died; exhibited bradydysrhythmias, ventricular tachycardia, or ventricular fibrillation; or experienced seizures after administration of lidocaine (95% confidence interval, 0% to 11%).
CONCLUSION: Despite theoretical concerns that lidocaine may enhance cocaine toxicity, the use of lidocaine in patients with cocaine-associated MI was not associated with significant cardiovascular or central nervous system toxicity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7492040     DOI: 10.1016/s0196-0644(95)70041-2

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  9 in total

Review 1.  Recreational drug misuse: issues for the cardiologist.

Authors:  A Ghuran; J Nolan
Journal:  Heart       Date:  2000-06       Impact factor: 5.994

Review 2.  Treatment of patients with cocaine-induced arrhythmias: bringing the bench to the bedside.

Authors:  Robert S Hoffman
Journal:  Br J Clin Pharmacol       Date:  2010-05       Impact factor: 4.335

Review 3.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

Review 4.  Role of voltage-gated sodium, potassium and calcium channels in the development of cocaine-associated cardiac arrhythmias.

Authors:  Michael E O'Leary; Jules C Hancox
Journal:  Br J Clin Pharmacol       Date:  2010-05       Impact factor: 4.335

Review 5.  Stimulant Drugs of Abuse and Cardiac Arrhythmias.

Authors:  Paari Dominic; Javaria Ahmad; Hajra Awwab; Md Shenuarin Bhuiyan; Christopher G Kevil; Nicholas E Goeders; Kevin S Murnane; James C Patterson; Kristin E Sandau; Rakesh Gopinathannair; Brian Olshansky
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-12-28

6.  The effect of amiodarone pretreatment on survival of mice with cocaine toxicity.

Authors:  Christopher R DeWitt; Nathan Cleveland; Richard C Dart; Kennon Heard
Journal:  J Med Toxicol       Date:  2005-12

7.  Radiofrequency ablation of drug refractory ventricular tachycardia related to cocaine use: a feasibility, safety, and efficacy study.

Authors:  Dhanunjaya Lakkireddy; Arun Kanmanthareddy; Mazda Biria; Yeruva Madhu Reddy; Jayasree Pillarisetti; Srijoy Mahapatra; Loren Berenbom; Larry Chinitz; Donita Atkins; Sudharani Bommana; Roderick Tung; Luigi DI Biase; Kalyanam Shivkumar; Andrea Natale
Journal:  J Cardiovasc Electrophysiol       Date:  2014-05-30

8.  Case files of the medical toxicology fellowship at the toxikon consortium in Chicago: cocaine-associated wide-complex dysrhythmias and cardiac arrest - treatment nuances and controversies.

Authors:  Ejaaz A Kalimullah; Sean M Bryant
Journal:  J Med Toxicol       Date:  2008-12

Review 9.  Prophylactic lidocaine for myocardial infarction.

Authors:  Arturo J Martí-Carvajal; Daniel Simancas-Racines; Vidhu Anand; Shrikant Bangdiwala
Journal:  Cochrane Database Syst Rev       Date:  2015-08-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.